Free News Archives
Latest Issue of OR Manager
May 2024

NIOSH rescinds approval for Pacific PPE N95 respirator masks

Editor's Note The National Institute for Occupational Safety and Health (NIOSH) announced on March 28 that it had honored a request by Pacific PPE Corp to rescind all of its N95 respirator mask approvals, effective immediately. Respirators with NIOSH approval numbers TC-84A-9278, TC-84A-9299, and TC-84A-9313 will no longer be manufactured,…

Read More

By: Judy Mathias
March 30, 2022
Share

Effect of music interventions on health-related quality of life

Editor's Note In this meta-analysis, researchers from Germany and Australia find that music-making and listening interventions are associated with positive changes in health-related quality of life. The systematic review and meta-analysis included 779 participants from 26 studies. Music interventions (ie, music listening, music therapy, singing, and gospel music) were linked…

Read More

By: Judy Mathias
March 29, 2022
Share

ANA says conviction of Tennessee nurse sets dangerous precedent

Editor's Note The American Nurses Association and Tennessee Nurses Association, on March 25, released a statement saying that the conviction of a former Vanderbilt University Medical Center nurse because of a fatal medication error made in 2017 sets a dangerous precedent. In the statement, they said: “We are deeply distressed…

Read More

By: Judy Mathias
March 29, 2022
Share

FDA: Class I recall of certain Celltrion USA COVID-19 test kits labeled for research use only

Editor's Note The Food and Drug Administration (FDA), on March 23, identified the recall by Celltrion USA of certain point of care DiaTrust COVID-19 Ag Rapid Test kits (labeled for research use only) as Class I, the most serious. The recall was initiated because the kits were distributed to customers…

Read More

By: Judy Mathias
March 29, 2022
Share

Racial disparities in COVID-19 outcomes of cancer patients

Editor's Note This multi-center study by cancer centers across the US finds that having cancer and COVID-19 is associated with worse outcomes in Black patients compared with White patients. Of 3,506 patients included in the analysis, 1,068 (30%) were Black and 2,438 (70%) were White. At the time of COVID-19…

Read More

By: Judy Mathias
March 28, 2022
Share

The Joint Commission seeking comments on proposed new, revised requirements to reduce healthcare disparities

Editor's Note The Joint Commission on March 23 announced that it is developing new and revised requirements on reducing healthcare disparities for its accreditation programs. A field review is open and seeking comments on the proposed new Leadership (LD) standard LD.04.03.08 as well as revisions to the Record of Care,…

Read More

By: Judy Mathias
March 28, 2022
Share

FDA: Class I recall of Philips Respironics V60, V60 Plus Ventilators

Editor's Note The Food and Drug Administration (FDA) on March 21 identified the recall by Philips Respironics of certain V60 and V60 Plus Ventilators as Class I, the most serious. The recall was initiated because a subset of these devices had parts that were put together using an expired adhesive.…

Read More

By: Judy Mathias
March 28, 2022
Share

VA recommends increasing its number of ASCs

Editor's Note On March 14, the Biden administration released a recommendation via the US Department of Veteran Affairs (VA) to restructure the VA healthcare system. OR Manager reported on the potential impact the recommended changes would have on VA services, which include older hospitals with unused inpatient beds being replaced…

Read More

By: Tarsilla Moura
March 25, 2022
Share

WHO: Takeaways on how 19 countries maintained health services during COVID-19

Editor's Note A December 2021 World Health Organization (WHO) report examines how 19 countries mitigated COVID-19’s effects on providing maternal; newborn; child and adolescent; and aging health services, JAMA Network March 15 reports. The WHO data comes from an initiative lasting from May 2020 to February 2021, during which groups…

Read More

By: Tarsilla Moura
March 25, 2022
Share

NIH begins clinical trial of three mRNA vaccines for HIV

Editor's Note According to a March 14 news release from the National Institutes of Health (NIH), NIH’s National Institute of Allergy and Infectious Diseases (NIAID) launched a Phase 1 clinical trial evaluating three experimental HIV vaccines using the messenger RNA (mRNA) technology. The mRNA technology being tested is the same…

Read More

By: Tarsilla Moura
March 25, 2022
Share
Live chat by BoldChat